For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves the way for complex touch sensation through brain stimulation, whilst using an extracorporeal bionic limb, that is attached to a chair or wheelchair.

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only specific bacteria in specific parts of the body.

As it stands, antibiotics kill bacteria indiscriminately.

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected. Researchers at the University Hospital Bonn (UKB) and the University of Bonn have now been able to show that local LLMs can help structure radiological findings in a privacy-safe manner, with all data remaining at the hospital. They compared various LLMs on public reports without data protection and on data-protected reports.

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery.

The proof-of-concept study, co-led by McGill University researchers Dr. Matthew Dankner and Dr. Reza Forghani, alongside an international team of clinicians and scientists, demonstrated the AI model can detect the presence of cancer cells in surrounding brain tissue with 85-per-cent accuracy.

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record on accurate diagnoses. Talking to other patients, she found they sometimes based choices on a physician’s personality or even the quality of their office furniture.

Across the United States, no hospital is the same. Equipment, staffing, technical capabilities, and patient populations can all differ. So, while the profiles developed for people with common conditions may seem universal, the reality is that there are nuances that require individual attention, both in the make-up of the patients being seen and the situations of the hospitals providing their care.

Autoimmune diseases, where the immune system mistakenly attacks the body's own healthy cells and tissues, often have a preclinical stage before diagnosis that’s characterized by mild symptoms or certain antibodies in the blood. However, in some people, these symptoms may resolve before culminating in the full disease stage.

Knowing who may progress along the disease pathway is critical for early diagnosis and intervention, improved treatment and better disease management,